Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular weekly insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

India and the UK establish strategic partnership in healthcare

Image

17-Nov-15 King's College Hospital has become the clinical partner for the first Indo UK Institute of Health, in New Chandigar, India. Backed by up to GBP100 mn of private investment, the project is the first of 11 which will see hospitals, nursing schools and medical colleges developed across India. The initiative will eventually amount to a GBP1 bn investment. [image: GOV UK]

Read More

Quality of care in Australian hospitals lacks oversight

Image

16-Nov-15 An OECD review of Australia's health system said that it was performing "remarkably well" despite its "fragmented nature" and the "sometimes strained" relationship between federal, state and territory governments over health funding. While Australia had improved its standards, it also mentioned: "A surprising lack of data on the quality and outcomes of care." [image: Merimbula News]

Read More

New course trains Russian doctors in telemedicine

Image

16-Nov-15 In May 2015, the People's Friendship University of Russia (PFUR or RUDN), which has students from 152 countries, established a school of medical information and telemedicine. There are few doctors in Russia who know how to run telemedicine centers, and RUDN is aiming to equip its students with this knowledge. [image: Russian Beyond The Headlines / Press Photo]

Read More

Japan’s generics market woos Indian firms

Image

16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

Read More
Share